Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Class Action
Pharma
Lawsuit points to alleged misconduct at Amgen-bought biotech
Investors who lost money in ChemoCentryx allege that the company had withheld or manipulated trial results on the firm’s since-approved drug Tavneos.
Angus Liu
Jul 25, 2025 11:18am
Pfizer ponies up $39M to resolve old pay-for-delay lawsuit
Apr 11, 2024 11:00am
J&J, IBM face class-action lawsuit over patient data breach
Sep 26, 2023 10:45am
Lawsuits filed over ineffective decongestants
Sep 15, 2023 10:37am
Alexion inks $125M deal to resolve investor lawsuit
Sep 14, 2023 11:41am
Shkreli and co. settle antitrust suit for $28M
Feb 1, 2022 3:40pm
